Pure Biologics establishes Doto Medical special purpose vehicle

Pure Biologics establishes the Doto Medical special purpose vehicle and signs an agreement with the renowned international business advisor Clairfield Partners to accelerate the commercialization of the PB103 aptamer project.

News

Inquiries

Pure Biologics begins in vivo studies in the PB004 project

28 March

2022

Pure Biologics begins in vivo studies in the PB004 project

Pure Biologics has signed a research agreement with The Jackson Laboratory, a leading US animal research services company operating worldwide, to launch the first in vivo preclinical pilot study in the PB004 project.

Pure Biologics becomes a partner of the Warsaw Health Innovation Hub

16 February

2022

Pure Biologics becomes a partner of the Warsaw Health Innovation Hub

February 15, 2022 Pure Biologics S.A. joined as a partner to the Warsaw Health Innovation Hub initiative, being under the aegis of the Medical Research Agency.

Agreement for the use of the PureApta platform with a guarantee of participation in future profits

3 February

2022

Agreement for the use of the PureApta platform with a guarantee of participation in future profits

Signing an agreement guaranteeing the distribution of profits from the commercialization of the aptamer

20 December

2021

We are moving!

On December 18, 2021, Pure Biologics signed a contract for the lease of space for a new headquarters.

Pure Biologics has licensed the patented technology platform PureApta to Novaptech

30 November

2021

Pure Biologics has licensed the patented technology platform PureApta to Novaptech

Pure Biologics has licensed the patented technology platform PureApta™, comprising chemical modifications of aptamers and their applications, to French company Novaptech, who offers tests, sensors and other solutions based on aptamers.

9 October

2020

Pure Biologics establishes Doto Medical special purpose vehicle

Pure Biologics begins in vivo studies in the PB004 project

Pure Biologics becomes a partner of the Warsaw Health Innovation Hub

Agreement for the use of the PureApta platform with a guarantee of participation in future profits

We are moving!

Pure Biologics has licensed the patented technology platform PureApta to Novaptech

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/2/20 25.01.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/1/20 21.01.2020